Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when?
- Correspondence to: Dr Michael P Jones, Director, Gastroenterology Laboratory, Northwestern University/Northwestern Memorial Hospital, Galter Pavilion 4–103, 251 E Huron Street, Chicago, IL 60611, USA; mpjones{at}nmh.org
- Received 6 February 2002
- Accepted 27 May 2002
Abstract
For patients with suboptimal relief from lifestyle modifications, acid suppressive therapy remains a cornerstone of treatment for gastro-oesophageal reflux disease (GORD). While a great deal of attention is focused on complications of GORD, adequate symptom relief remains an important and practical therapeutic goal. Adequate symptom relief is an achievable and easily measurable endpoint that both restores quality of life and prevents many potential complications.
